AMU Co-Hosts World Congress on Nanomedicine; AMU Faculty Member Presents Cancer Research in Delhi
ALIGARH, September 30: Aligarh Muslim University (AMU) was among the co-hosts of the World Congress on Nanomedicine 2026 held at Vigyan Bhawan, New Delhi, where Prof. Mohammad Azhar Aziz, Professor and Founder Director, Cancer Nanomedicine Consortium, AMU, presented research on the use of nanomedicine to restore the function of a tumour suppressor gene.
Prof. Aziz delivered an invited lecture titled “Nanomedicine Approach to Restore the Function of a Novel Tumour Suppressor Gene” at the three-day international congress, which brought together scientists, clinicians, researchers and young investigators from India and abroad. He was also a member of the National Advisory Committee of the Congress.
The Congress, held under the chairmanship of Nobel laureate Prof. Roger Kornberg and hosted by the Institute of Nano Medical Sciences, University of Delhi, focused on emerging applications of nanotechnology in medicine.
Prof. Aziz’s presentation highlighted an emerging area of cancer research in which nanotechnology is being explored to address molecular abnormalities associated with cancer. His work brings together nanotechnology, cancer biology, molecular medicine and precision oncology, reflecting the growing importance of interdisciplinary approaches in developing new therapeutic strategies.
His association with the Congress in both scientific and advisory capacities also placed AMU’s ongoing work in cancer nanomedicine within a wider national and international research forum.
The Cancer Nanomedicine Consortium at AMU, founded by Prof. Aziz, brings together researchers and clinicians from multiple disciplines for collaborative work in cancer diagnosis, targeted therapeutics and precision medicine. AMU’s Interdisciplinary Nanotechnology Centre also works at the interface of nanotechnology and biomedical sciences.
Prof. Aziz emphasised that interdisciplinary collaboration is essential for translating advances in nanotechnology into biological and clinical applications. The Congress provided AMU researchers an opportunity to engage with the wider nanomedicine community and explore research collaborations.
